The DDC will be happening in Barcelona for the first time, Dec3-5. One of the best drug discovery conferences crossing the Atlantic and landing in Europe. Do not miss this chance to listen to great talks, exchange and network.
Our CSO Victor Guallar, also the group leader of the EAPM lab at BSC, will be one of the speakers.
He will discuss the potential of AI for polypharmacology, and how we are exploring this path at Nostrum Biodiscovery.
Details of the talk:
Thu 5 Dec 08:30
Can AI Give Us the Dreamed-of True Polypharmacology Solutions?
Everybody agrees that finding small molecules that can bind specifically to selected 2-3 targets (not to hundreds of anti-targets) is the ultimate drug design goal for complex diseases. While this has been limited to serendipity or to some flavour of (mostly inefficient) merging/fusing/linking approach, now AI is allowing us to dream of finding true small molecule polypharmacology. We will introduce our efforts in this line and recent implementation studies, demonstrating that such a dream is possible today.
